This report was first published by Endpoints News. To see the original version, click here
A diluted form of the Biosecure Act appears close to becoming law, after the House on Wednesday approved a defense bill that includes the measure.
Biosecure would restrict federal contracts with some Chinese biotech firms. Its advancement is notable after lawmakers declined to place it in last year’s defense package.
您已閱讀22%（407字），剩余78%（1417字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。